Dr. Yeyan Zhang Resigns as a Director



    BURNABY, BC, Oct. 6 /CNW/ - Welichem Biotech Inc. (the "Company") (TSX-V:
WBI), announced that Dr. Yeyan Zhang has resigned as a director of the Company
for personal reasons. The Company has greatly valued Dr. Yeyan Zhang's
contribution as a director of the Company for the past few years.

    
    About Welichem Biotech Inc.
    ---------------------------
    Welichem Biotech Inc. is a publicly-traded biotechnology company
developing therapeutic drugs in the fields of autoimmune diseases and cancer.

    ON BEHALF OF THE BOARD

    Genhui Chen
    Chief Executive Officer
    

    The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy or accuracy of the content of this news
release. This press release contains forward-looking statements that include
our belief as to the potential of our products. Certain risks and
uncertainties such as our ability to successfully commercialize the products
could cause the Company's actual results to differ materially from those in
the forward-looking statements.

    %SEDAR: 00021386E




For further information:

For further information: Genhui Chen, Tel.: (604) 432-1703, Email:
gchen@welichem.com

Organization Profile

Welichem Biotech Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890